Salwa
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Drug Solubulity and Delivery Systems 5
- Advanced Drug Delivery Systems 5
- Advancements in Transdermal Drug Delivery 3
-
- RNA Interference and Gene Delivery 3
- Co-authors
- Lalit Kumar (20 shared papers)Srinivas Reddy Jitta (8 shared papers)Navya Ajitkumar Bhaskaran (7 shared papers)Shirleen Miriam Marques (6 shared papers)Ruchi Verma (6 shared papers)Nidhi Raval (1 shared paper)Vivek P. Chavda (1 shared paper)Ben Zhong Tang (1 shared paper)
- Journals
- International Journal of Biological Macromolecules (3 papers)Journal of Pharmaceutical Innovation (2 papers)Journal of Drug Delivery Science and Technology (2 papers)Journal of Controlled Release (1 paper)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)
- Partner nations
- IndiaUnited StatesHong Kong
In The Last Decade
Salwa
27 papers receiving 435 citations
Peers
Comparison fields: 5 of 88
- Pharmaceutical Science 129
- Biomaterials 65
- Analytical Chemistry 38
- Dermatology 23
- Molecular Medicine 12
Countries citing papers authored by Salwa
This map shows the geographic impact of Salwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salwa more than expected).
Fields of papers citing papers by Salwa
This network shows the impact of papers produced by Salwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salwa. The network helps show where Salwa may publish in the future.
Co-authors
The 25 scholars most cited alongside Salwa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 114 | |
| 2 | 2021 | 44 | |
| 3 | 2022 | 38 | |
| 4 | 2023 | 27 | |
| 5 | 2019 | 26 | |
| 6 | 2023 | 24 | |
| 7 | 2021 | 24 | |
| 8 | 2024 | 18 | |
| 9 | 2022 | 17 | |
| 10 | 2021 | 13 | |
| 11 | 2023 | 12 | |
| 12 | 2007 | 12 | |
| 13 | 2022 | 11 | |
| 14 | 2022 | 11 | |
| 15 | 2023 | 9 | |
| 16 | 2022 | 7 | |
| 17 | 2023 | 6 | |
| 18 | 2023 | 6 | |
| 19 | 2025 | 5 | |
| 20 | Lymphoid tyrosine phosphatase R620W variant and inflammatory bowel disease in Tunisia | 2010 | 4 |
About Salwa
Salwa is a scholar working on Pharmaceutical Science, Molecular Biology, Infectious Diseases, Biomaterials and Analytical Chemistry, having authored 28 papers that have together received 443 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (5 papers), Advanced Drug Delivery Systems (5 papers), Analytical Methods in Pharmaceuticals (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Advancements in Transdermal Drug Delivery (3 papers), RNA Interference and Gene Delivery (3 papers), HIV-related health complications and treatments (3 papers) and HIV Research and Treatment (3 papers). The work is most often cited by research in Pharmaceutical Science (129 citations), Biomaterials (65 citations), Analytical Chemistry (38 citations), Dermatology (23 citations) and Molecular Medicine (12 citations). Salwa has collaborated with scholars based in India, United States and Hong Kong. Frequent co-authors include Lalit Kumar, Srinivas Reddy Jitta, Navya Ajitkumar Bhaskaran, Shirleen Miriam Marques, Ruchi Verma, Nidhi Raval, Vivek P. Chavda, Ben Zhong Tang, Yanhong Duo and Lalitkumar K. Vora. Their work appears in journals such as International Journal of Biological Macromolecules, Journal of Pharmaceutical Innovation, Journal of Drug Delivery Science and Technology, Journal of Controlled Release and Naunyn-Schmiedeberg s Archives of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.